← back to search

Xinghu Zhang

Second Affiliated Hospital of Nanjing Medical University · CN
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Neuroinflammation and Neurodegeneration Mechanisms, and Autoimmune Neurological Disorders and Treatments.
h-index
25
citations
2,061
works
185
NIH funding
primary concept
email

Recent publications

Spatiotemporal subtypes of brain and spinal cord atrophy in neuromyelitis optica spectrum disorders and multiple sclerosis
BMC Medicine 2025cited by 2position: middledoi
Corrigendum to A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study Lancet Reg Health West Pac (2023) 38: 100846
The Lancet Regional Health - Western Pacific 2025cited by 1position: middledoi
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis
European Journal of Neurology 2024cited by 39position: middledoi
Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases
Brain 2024cited by 8position: middledoi
Development of a short-term prognostic model for anti-N-methyl-D-aspartate receptor encephalitis in Chinese patients
BMC Neurology 2024cited by 7position: middledoi
Spatial structural abnormality maps associated with cognitive and physical performance in relapsing-remitting multiple sclerosis
European Radiology 2024cited by 3position: middledoi
Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter study
Chinese Medical Journal 2024cited by 2position: middledoi
A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study
The Lancet Regional Health - Western Pacific 2023cited by 26position: middledoi
Cerebellar connectome alterations and associated genetic signatures in multiple sclerosis and neuromyelitis optica spectrum disorder
Journal of Translational Medicine 2023cited by 15position: middledoi
Independent and reproducible hippocampal radiomics biomarkers for multisite multiple sclerosis and neuromyelitis optica spectrum disorders
Multiple Sclerosis and Related Disorders 2023cited by 5position: middledoi
Evidence-based expert consensus on the management of primary central nervous system lymphoma in China
Journal of Hematology & Oncology 2022cited by 70position: middledoi
Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS
Journal of Neurology Neurosurgery & Psychiatry 2021cited by 59position: middledoi
Structural and functional hippocampal alterations in Multiple sclerosis and neuromyelitis optica spectrum disorder
Multiple Sclerosis Journal 2021cited by 17position: middledoi
Subtyping relapsing–remitting multiple sclerosis using structural MRI
Journal of Neurology 2021cited by 14position: middledoi
Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018
Frontiers in Neurology 2021cited by 13position: middledoi
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
The Lancet Neurology 2020cited by 272position: middledoi
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders
Neurology Neuroimmunology & Neuroinflammation 2020cited by 88position: middledoi
Validation of the NEOS score in Chinese patients with anti-NMDAR encephalitis
Neurology Neuroimmunology & Neuroinflammation 2020cited by 26position: middledoi
C1Q/TNF-related protein 4 expression correlates with herpes simplex encephalitis progression
Annals of Translational Medicine 2019cited by 10position: middledoi
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis
Chinese Medical Journal 2018cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fu‐Dong Shi · Inserm8 papers (2020–2025)De‐Cai Tian · Barrow Neurological Institute7 papers (2021–2025)Fuqing Zhou · Nanchang University6 papers (2021–2025) · 6 papers (2021–2025)Zhizheng Zhuo · Shanxi Medical University6 papers (2021–2025)Kuncheng Li · Southwest Petroleum University4 papers (2021–2024)Wei Qiu · Sun Yat-sen University4 papers (2018–2024)Frederik Barkhof · The Queen's Medical Research Institute4 papers (2021–2024)Yuxin Li · Fudan University4 papers (2021–2023)Haiqing Li · Fudan University4 papers (2021–2024)Xuemei Han · Union Hospital4 papers (2021–2024)Guanmei Cao · Shandong University4 papers (2021–2025)Ningnannan Zhang · Tianjin University4 papers (2021–2024)Meini Zhang · Shanxi Medical University4 papers (2018–2024)Sven Haller · Internal Displacement Monitoring Centre3 papers (2021–2025)Chunshui Yu · Ningbo University3 papers (2020–2021) · 3 papers (2024–2025)Bitao Bu · Tongji Hospital3 papers (2018–2024)Yongmei Li · Nanchang University3 papers (2021–2024)Yaou Liu · Anhui University3 papers (2021–2024)